UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.199

Sortiert nach

Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials

European heart journal, 2014-09, Vol.35 (33), p.2249-2259

2014

Link zum Volltext

Verfügbarkeit prüfen

Stroke Volume/Pulse Pressure Ratio and Cardiovascular Risk in Arterial Hypertension

Hypertension (Dallas, Tex. 1979), 1999-03, Vol.33 (3), p.800-805

1999

Link zum Volltext

Verfügbarkeit prüfen

Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk

Journal of the American College of Cardiology, 1995-04, Vol.25 (5), p.1056-1062

1995

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy with amlodipine/valsartan in essential hypertension: a 52-week, randomised, open-label, extension study

International journal of clinical practice (Esher), 2010-09, Vol.64 (10), p.1367-1374

2010

Link zum Volltext

Verfügbarkeit prüfen

Midwall left ventricular mechanics : an independent predictor of cardiovascular risk in arterial hypertension

Circulation (New York, N.Y.), 1996-01, Vol.93 (2), p.259-265

1996

Link zum Volltext

Verfügbarkeit prüfen

Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension

Annals of internal medicine, 1991-03, Vol.114 (5), p.345

1991

Link zum Volltext

Verfügbarkeit prüfen

Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease

European heart journal, 1993-07, Vol.14 (suppl-D), p.8-15

1993

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of combined local mechanical vibrations, continuous passive motion and thermotherapy in the management of osteoarthritis of the knee

Osteoarthritis and cartilage, 2009-10, Vol.17 (10), p.1269-1274

2009

Link zum Volltext

Verfügbarkeit prüfen

Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: the LIFE study

Journal of human hypertension, 2004-06, Vol.18 (6), p.411-416

2004

Link zum Volltext

Verfügbarkeit prüfen

Comparison of classification of the severity of hypertension by blood pressure level and by World Health Organization criteria in the prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertension

Journal of hypertension, 1993-12, Vol.11 (12), p.1429-1440

1993

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Left Ventricular Mass and Geometry in Black and White Patients With Essential Hypertension

American journal of hypertension, 1993-10, Vol.6 (10), p.815-823

1993

Link zum Volltext

Verfügbarkeit prüfen

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

The New England journal of medicine, 2010-12, Vol.363 (25), p.2406-2415

2010

Link zum Volltext

Verfügbarkeit prüfen

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145): A Pooled Analysis of More Than 1,300 Patients in 4 Phase II Trials

Journal of the American College of Cardiology, 2014-04, Vol.63 (13), p.1278-1288

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension

Journal of hypertension, 2001-01, Vol.19 (1), p.119-125

2001

Link zum Volltext

Verfügbarkeit prüfen

The preferences for everyday living inventory: scale development and description of psychosocial preferences responses in community-dwelling elders

The Gerontologist, 2013-08, Vol.53 (4), p.582-595

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy

Journal of the American College of Cardiology, 2012-06, Vol.59 (25), p.2344-2353

2012

Link zum Volltext

Verfügbarkeit prüfen

Prevalence estimates of cognitive impairment in medical model adult day health care programs

Social Psychiatry and Psychiatric Epidemiology, 1998-06, Vol.33 (6), p.283-290

1998

Link zum Volltext

Verfügbarkeit prüfen

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)

Journal of the American College of Cardiology, 2014-04, Vol.63 (13), p.1278-1288

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy (the LIFE study)

The American journal of cardiology, 2001-09, Vol.88 (6), p.646-650

2001

Link zum Volltext

Verfügbarkeit prüfen

Continuous Quality Improvement as an Innovation: Which Nursing Facilities Adopt It?

The Gerontologist, 2005-02, Vol.45 (1), p.68-77

2005

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics the alliance study

Journal of the American College of Cardiology, 2004-11, Vol.44 (9), p.1772-1779

2004

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Behavior Disorder and Disturbance to Family and Staff in a Sample of Adult Day Health Care Clients

The Gerontologist, 1997-10, Vol.37 (5), p.629-639

1997

Link zum Volltext

Verfügbarkeit prüfen

Left Ventricular Mass as a Predictor of Development of Hypertension

American journal of hypertension, 1991-11, Vol.4 (11S), p.603S-607S

1991

Link zum Volltext

Verfügbarkeit prüfen

Left Ventricular Hypertrophy Associated with Hypertension and Its Relevance as a Risk Factor for Complications

Journal of cardiovascular pharmacology, 1993, Vol.21 Suppl 2, p.S38-S44

1993

Link zum Volltext

Verfügbarkeit prüfen

A Primary Care Nursing Model in Long-Term Care Facilities: Evaluation of Impact on Affect, Behavior, and Socialization

The Gerontologist, 1993-10, Vol.33 (5), p.667-674

1993

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(956)
Mit Volltextzugriff
(1.027)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials

Stroke Volume/Pulse Pressure Ratio and Cardiovascular Risk in Arterial Hypertension

Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk

Combination therapy with amlodipine/valsartan in essential hypertension: a 52-week, randomised, open-label, extension study

Midwall left ventricular mechanics : an independent predictor of cardiovascular risk in arterial hypertension

Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension

Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease

Efficacy of combined local mechanical vibrations, continuous passive motion and thermotherapy in the management of osteoarthritis of the knee

Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: the LIFE study

Comparison of classification of the severity of hypertension by blood pressure level and by World Health Organization criteria in the prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertension

Comparison of Left Ventricular Mass and Geometry in Black and White Patients With Essential Hypertension

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145): A Pooled Analysis of More Than 1,300 Patients in 4 Phase II Trials

Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension

The preferences for everyday living inventory: scale development and description of psychosocial preferences responses in community-dwelling elders

Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy

Prevalence estimates of cognitive impairment in medical model adult day health care programs

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)

Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy (the LIFE study)

Continuous Quality Improvement as an Innovation: Which Nursing Facilities Adopt It?

Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics the alliance study

Prevalence of Behavior Disorder and Disturbance to Family and Staff in a Sample of Adult Day Health Care Clients

Left Ventricular Mass as a Predictor of Development of Hypertension

Left Ventricular Hypertrophy Associated with Hypertension and Its Relevance as a Risk Factor for Complications

A Primary Care Nursing Model in Long-Term Care Facilities: Evaluation of Impact on Affect, Behavior, and Socialization

Suchergebnisse filtern